656800-40-7 | 2-methyl-6-((trimethylsilanyl)ethynyl)pyridine

5315-25-3    1066-54-2    656800-40-7 

[1]CurrentPatentAssignee:ABBVIEINC-US2014/148461,2014,A1Locationinpatent:Paragraph0345-0346

[2]Alagille,David;Baldwin,RonaldM.;Roth,BryanL.;Wroblewski,JardaT.;Grajkowska,Ewa;Tamagnan,GillesD.[BioorganicandMedicinalChemistryLetters,2005,vol.15,#4,p.945-949]

[3]Alagille,David;Baldwin,RonaldM.;Roth,BryanL.;Wroblewski,JardaT.;Grajkowska,Ewa;Tamagnan,GillesD.[BioorganicandMedicinalChemistry,2005,vol.13,#1,p.197-209]

[4]Locationinpatent:schemeortableZhang,Peng;Zou,Mu-Fa;Rodriguez,AliceL.;JeffreyConn;Newman,AmyHauck[BioorganicandMedicinalChemistry,2010,vol.18,#9,p.3026-3035]

[5]CurrentPatentAssignee:BASFSE-WO2014/202703,2014,A1Locationinpatent:Page/Pagecolumn102;103

[6]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2004/13125,2004,A1Locationinpatent:Page18-19

[7]Bach,Peter;Nilsson,Karolina;Svensson,Tor;Bauer,Udo;Hammerland,LanceG.;Peterson,Alecia;Wallberg,Andreas;Oesterlund,Krister;Karis,David;Boije,Maria;Wensbo,David[BioorganicandMedicinalChemistryLetters,2006,vol.16,#18,p.4788-4791]

[8]CurrentPatentAssignee:ASTRAZENECAPLC;TAKEDAPHARMACEUTICALCOMPANYLIMITED-WO2005/44267,2005,A1Locationinpatent:Page/Pagecolumn24

[9]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED;ASTRAZENECAPLC-WO2005/44266,2005,A1Locationinpatent:Page/Pagecolumn21

[10]CurrentPatentAssignee:C.H.BoehringerSohnAG&Co.KG-WO2009/76747,2009,A1Locationinpatent:Page/Pagecolumn90

[11]Locationinpatent:schemeortableAlagille,David;Dacosta,Herve;Chen,Yelin;Hemstapat,Kamondanai;Rodriguez,Alice;Baldwin,RonaldM.;Conn,JeffreyP.;Tamagnan,GillesD.[BioorganicandMedicinalChemistryLetters,2011,vol.21,#11,p.3243-3247]

[12]Keck,ThomasM.;Zou,Mu-Fa;Zhang,Peng;Rutledge,RebeccaP.;Newman,AmyHauck[ACSMedicinalChemistryLetters,2012,vol.3,#7,p.544-549]

[13]Röse,Philipp;Pünner,Florian;Hilt,Gerhard;Harms,Klaus[Synlett,2013,vol.24,#9,p.1101-1104]

[14]Joseph,MohammedCassiem;Swarts,AndrewJohn;Mapolie,SelwynFrank[AppliedOrganometallicChemistry,2020,vol.34,#5]

[15]CurrentPatentAssignee:THERAVANCEBIOPHARMA,INC.-WO2021/102468,2021,A1Locationinpatent:Paragraph226;254;255

33733-73-2    656800-40-7   

2-methyl-6-(3-methylsulfanyl-phenylethynyl)-pyridine 

[1]BioorganicandMedicinalChemistry,2005,vol.13,p.197-209

656800-40-7    30413-58-2 

[1]BioorganicandMedicinalChemistryLetters,2006,vol.16,p.4788-4791

[2]Patent:WO2005/44267,2005,A1.Locationinpatent:Page/Pagecolumn24-25

[3]Patent:WO2014/202703,2014,A1.Locationinpatent:Page/Pagecolumn102;103

[4]Patent:WO2004/13125,2004,A1.Locationinpatent:Page19

[5]Patent:WO2004/13135,2004,A1.Locationinpatent:Page43

[6]BioorganicandMedicinalChemistry,2005,vol.13,p.197-209

[7]Synlett,2013,vol.24,p.1101-1104

[8]AppliedOrganometallicChemistry,2020,vol.34

591-50-4    656800-40-7    96206-92-7 

[1]Jaeschke,Georg;Porter,Richard;Buettelmann,Bernd;Ceccarelli,SimonaM.;Guba,Wolfgang;Kuhn,Bernd;Kolczewski,Sabine;Huwyler,Joerg;Mutel,Vincent;Peters,Jens-Uwe;Ballard,Theresa;Prinssen,Eric;Vieira,Eric;Wichmann,Juergen;Spooren,Will[BioorganicandMedicinalChemistryLetters,2007,vol.17,#5,p.1307-1311]

1033602-66-2    656800-40-7    1160219-20-4 

[1]Locationinpatent:experimentalpartKulkarni,SantoshS.;Zou,Mu-Fa;Cao,Jianjing;Deschamps,JeffreyR.;Rodriguez,AliceL.;Conn,P.Jeffrey;Newman,AmyHauck[JournalofMedicinalChemistry,2009,vol.52,#11,p.3563-3575]